Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis

Cited by (893)

Items 101–200 of 893

1. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort
   Marian Troelstra, Julia J. Witjes, Anne‐Marieke van Dijk, Anne Linde Mak, Oliver J. Gurney‐Champion, Jurgen Henk Runge, Diona Zwirs, Daniela Stols‐Gonçalves, Aelko H. Zwinderman, Marije ten Wolde et al. · 2021 · Journal of Magnetic Resonance Imaging
2. Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD
   Gidener, Tolga, Dierkhising, Ross A., Mara, Kristin C., Therneau, Terry M., Venkatesh, Sudhakar K., Ehman, Richard L., Yin, Meng, Allen, Alina M. · 2023 · Hepatology
3. Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
   Tina Reinson, Ryan Malcolm Buchanan, Christopher D. Byrne · 2022 · Clinical and Molecular Hepatology
4. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
   Marina V. Maevskaya, Yu. V. Kotovskaya, Vladimir T Ivashkin, О. Н. Ткачева, Ekaterina Anatol'evna Troshina, Marina Vladimirovna Shestakova, Valeriy Vladimirovich Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Е. N. Dudinskaya et al. · 2022 · Terapevticheskii arkhiv
5. Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease
   Nobuharu Tamaki, Masayuki Kurosaki, Daniel Q. Huang, Rohit Seth Loomba · 2022 · Hepatology Research
6. Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
   Jung Hwan Yu, Han Ah Lee, Seung Up Kim · 2022 · Clinical and Molecular Hepatology
7. Clinical relevance of liver histopathology and different histological classifications of NASH in adults
   Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez‐Pinto, Giovanni Targher, Amedeo Lonardo · 2017 · Expert Review of Gastroenterology & Hepatology
8. Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?
   Jeffrey Thomas Budd, Kenneth J. Cusi · 2020 · The American Journal of Medicine
9. Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
   Yasser Mahrous Fouad, Mohamed Aly Abdelkhalek Alboraie, Gamal El-Sayed Shiha · 2024 · Hepatology International
10. Relationship between three commonly used non‐invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non‐alcoholic steatohepatitis
    Naga Chalasani, Manal F. Abdelmalek, Rohit Seth Loomba, Kris V. Kowdley, Arthur J. McCullough, Srinivasan Dasarathy, Brent A. Neuschwander‐Tetri, Norah A. Terrault, Beatrice Ferguson, Reshma Shringarpure et al. · 2018 · Liver International
11. CHI3L1 in the pathophysiology and diagnosis of liver diseases
    Shuwei Wang, Meng‐Yuan Hu, Yun-Song Qian, Zhenluo Jiang, Lili Shen, Liyun Fu, Yaoren Hu · 2020 · Biomedicine & Pharmacotherapy
12. The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics
    James Neuberger, Owen Lawrence Cain · 2021 · Hepatic Medicine Evidence and Research
13. Diabetes and metabolic dysfunction-associated fatty liver disease
    Timothy M. E. Davis · 2021 · Metabolism
14. Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study
    Kiminori Kimura, Tatsuya Kanto, Shinji Shimoda, Kenichi Harada, Masamichi Kimura, Koji Nishikawa, Jun Imamura, Eiichi Ogawa, Masanao Saio, Yoshihiro Ikura et al. · 2022 · EBioMedicine
15. A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic Approaches
    Francesco Giangregorio, Emilio Mosconi, Maria Grazia Debellis, Stella Provini, Ciro Esposito, Matteo Garolfi, Simona Oraka, OLGA KALOUDI, Gunel Mustafazade, Raquel Marín‐Baselga et al. · 2024 · Journal of Clinical Medicine
16. Transient versus two-dimensional shear-wave elastography in a multistep strategy to detect advanced fibrosis in NAFLD
    Cassinotto, Christophe, Boursier, Jérome, Paisant, Anita, Guiu, Boris, Irles‐Depe, Marie, Canivet, Clémence, Aube, Christophe, de Ledinghen, Victor · 2021 · Hepatology
17. Non-invasive tests of non-alcoholic fatty liver disease
    Guanlin Li, Xinrong Zhang, Huapeng Lin, Lilian Yan Liang, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong · 2022 · Chinese Medical Journal
18. Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Sangsoo Han, Miyoung Choi, Bora Lee, Hye Won Lee, Seong Hee Kang, Yuri Cho, Sang Bong Ahn, Do Seon Song, Dae Won Jun, Ji-Eun Lee et al. · 2022 · Gut and Liver
19. Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis
    Narges Azizi, Hamed Naghibi, Madjid Shakiba, Mina Morsali, Diana Zarei, Hedayat Abbastabar, Hossein Ghanaati · 2024 · European Radiology
20. Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non‐alcoholic fatty liver disease from tertiary care centres
    Maéva Guillaume, Valerie Moal, Cyrielle Delabaudière, Floraine Zuberbuhler, Marie‐Angèle Robic, Adrien Lannes, Sophie Métivier, Frédéric Oberti, Pierre Gourdy, Isabelle Fouchard‐Hubert et al. · 2019 · Alimentary Pharmacology & Therapeutics
21. Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations
    Marco A. Arrese, Francisco Barrera M., Nicolás Triantafilo, Juan Pablo Arab · 2019 · Expert Review of Gastroenterology & Hepatology
22. A critical appraisal of the use of ultrasound in hepatic steatosis
    Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica · 2019 · Expert Review of Gastroenterology & Hepatology
23. Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease
    Jérémy Dana, Aïna Venkatasamy, Antonio Saviano, Joachim Lupberger, Yujin Hoshida, Valérie Vilgrain, Pierre Nahon, Caroline Reinhold, B. Gallix, Thomas F. Baumert · 2022 · Hepatology International
24. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Haofei Hu, Yong Yun Han, Changchun Cao, Yongcheng He · 2022 · Journal of Translational Medicine
25. Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
    Arthur Berger, Sarah Shili, Floraine Zuberbuhler, Jean‐Baptiste Hiriart, Adrien Lannes, Faïza Chermak, Gilles Hunault, Juliette Foucher, F. Oberti, Isabelle Fouchard‐Hubert et al. · 2019 · Clinical and Translational Gastroenterology
26. Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
    Hyeok‐Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung‐Wan Lee, Eun Seok Kang, Seok Won Park, Bong Soo, Eun Jig Lee, Yong‐ho Lee et al. · 2020 · Cardiovascular Diabetology
27. Pediatric MASLD: current understanding and practical approach
    Anne-Sophie R Stroes, Miriam B. Vos, Marc Alexander Benninga, Bart G.P. Koot · 2024 · European Journal of Pediatrics
28. Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
    Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, Nor Azian Abdul Murad · 2021 · Biomedicines
29. Liver fibrosis quantification
    Sudhakar Kundapur Venkatesh, Michael S Torbenson · 2022 · Abdominal Radiology
30. Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases?
    Jimmy Che‐To Lai, Lilian Yan Liang, Grace Lai‐Hung Wong · 2023 · Gastroenterology report
31. Metabolic‐associated fatty liver disease (MAFLD) in coeliac disease
    Antonio Rispo, Nicola Imperatore, Maria Guarino, Raffaella Tortora, Anna Alisi, Valentina Cossiga, Anna Testa, Simona Ricciolino, Andrea Fiorentino, Filomena Morisco · 2020 · Liver International
32. Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non‐alcoholic fatty liver disease
    Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Kento Imajo, Masato Yoneda, Miwa Kawanaka, Hiroyuki Kirikoshi, Masafumi Ono, Masataka Taguri et al. · 2018 · Journal of Gastroenterology and Hepatology
33. Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities
    Wojciech Trzépizur, Jérôme Boursier, Marc Le Vaillant, Pierre‐Henri Ducluzeau, Severine G. Dubois, Samir Henni, Pierre Abraham, Christophe Aubé, Paul Calès, Frédéric Gagnadoux · 2018 · European Respiratory Journal
34. Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study
    Katsutoshi Sugimoto, Dong Ho Lee, Jae Young Lee, Su Jong Yu, Fuminori Moriyasu, Kentaro Sakamaki, Hisashi Oshiro, Hiroshi Takahashi, Tatsuya Kakegawa, Yusuke Tomita et al. · 2021 · Radiology
35. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis
    Rohit Seth Loomba, Anjali Jain, Anna Mae Diehl, Cynthia D. Guy, Dana D. Portenier, Ranjan Sudan, Seema Singh, Claire Faulkner, Lisa Richards, Kelly D. Hester et al. · 2018 · Clinical Gastroenterology and Hepatology
36. Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease
    José Altamirano, Qiaochu Qi, Sabina Choudhry, Mohamed Abdallah, Ashwani Kumar Singal, Abhinav Humar, Ramon A. Bataller, Amir Ali Borhani, Andrés Duarte‐Rojo · 2020 · Translational Gastroenterology and Hepatology
37. Ultrasound-based liver elastography: current results and future perspectives
    Cheng Fang, Paul Singh Sidhu · 2020 · Abdominal Radiology
38. Recent advances in understanding and managing non-alcoholic fatty liver disease
    Somaya A. M. Albhaisi, Arun Jayant Sanyal · 2018 · F1000Research
39. Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy
    Yuanzi Liang, Daowei Li · 2020 · BMC Gastroenterology
40. Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease
    Luca Miele, Maria Assunta Zocco, Fabrizio Pizzolante, Nicoletta De Matthaeis, Maria Elena Ainora, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Gianludovico Rapaccini · 2020 · Metabolism
41. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
    Saleh A. Alqahtani, Pegah Golabi, James M. Paik, Brian P Lam, Amir H. Moazzez, Hazem A. Elariny, Zachary D Goodman, Zobair M. Younossi · 2021 · Obesity Surgery
42. Simple Scores of Fibrosis and Mortality in Patients with NAFLD: A Systematic Review with Meta-Analysis
    Federico Salomone, Agnieszka Micek, Justyna Godos · 2018 · Journal of Clinical Medicine
43. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease
    Nicolás Salva-Pastor, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño‐Lámbarri · 2019 · The Journal of Steroid Biochemistry and Molecular Biology
44. Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
    Jeong Woo Kim, Young‐Sun Lee, Yang Shin Park, Baek‐hui Kim, Soo Yeon Lee, Jong Eun Yeon, Chang Hee Lee · 2020 · Scientific Reports
45. Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease
    Joeri Lambrecht, Frank Tacke · 2021 · Frontiers in Immunology
46. Changing clinical management of NAFLD in Asia
    Takuma Nakatsuka, Ryosuke Tateishi, Kazuhiko Koike · 2021 · Liver International
47. Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease
    Yingzhen N. Zhang, Kathryn Jane Fowler, Andrew S. Boehringer, Vivian Montes, Alexandra N. Schlein, Yesenia Covarrubias, Tanya J. Wolfson, Cheng William Hong, Mark A. Valasek, Michael P. André et al. · 2021 · European Radiology
48. Elevated C-reactive protein mediates the liver-brain axis: a preliminary study
    Jiang, Rongtao, Wu, Jing, Rosenblatt, Matthew, Dai, Wei, Rodriguez, Raimundo X., Sui, Jing, Qi, Shile, Liang, Qinghao, Xu, Bin, Meng, Qinghua et al. · 2023 · eBioMedicine
49. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort
    Stergios A. Pοlyzos, Aristidis Slavakis, Georgios Koumerkeridis, Panagiotis Katsinelos, Jannis Kountouras · 2018 · Hormone and Metabolic Research
50. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma
    Felipe B. Maegawa, Lauren Shehorn, Hassan Aziz, John B. Kettelle, Tun Jie, Taylor Sohn Riall · 2019 · JAMA Network Open
51. Case-finding strategies in non-alcoholic fatty liver disease
    Jérôme Boursier, Emmanuel A. Tsochatzis · 2020 · JHEP Reports
52. NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea
    Jiyoon Park, Eunice Yewon Lee, Jie Li, Mi Jung Jun, Eileen Laureal Yoon, Sang Bong Ahn, Chuanli Liu, Hongli Yang, Fajuan Rui, Biyao Zou et al. · 2021 · Digestive Diseases
53. NAFLD in type 1 diabetes: overrated or underappreciated?
    Jonathan Mertens, Luc F. Van Gaal, Sven Francque, Christophe E.M. De Block · 2021 · Therapeutic Advances in Endocrinology and Metabolism
54. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
    Xiaoli Pan, Yanqiao Zhang · 2022 · Chinese Medical Journal
55. Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease
    Amandeep Singh, Falgun Gosai, Mohamed Tausif Siddiqui, Mohit Gupta, Rocío López, Eric Lawitz, Fred F Poordad, William W. Carey, Arthur J. McCullough, Naim Alkhouri · 2020 · Journal of Clinical Gastroenterology
56. Diagnostic accuracy of fibrosis tests in children with non‐alcoholic fatty liver disease: A systematic review
    Laura G. Draijer, Janneke P. M. van Oosterhout, Yasaman Vali, Sabrina L M Zwetsloot, Johanna H. van der Lee, Faridi S. van Etten‐Jamaludin, Malika Chegary, Marc Alexander Benninga, Bart G.P. Koot · 2021 · Liver International
57. Screening for nonalcoholic fatty liver disease-when, who and how?
    Christoph G. Dietrich, Monika Rau, Andreas Geier · 2021 · World Journal of Gastroenterology
58. Ultrasound Elastography: Basic Principles and Examples of Clinical Applications with Artificial Intelligence—A Review
    Maurizio Cè, Natascha Claudia D’Amico, Giulia Maria Danesini, Chiara Foschini, Giancarlo Oliva, Carlo Maria Andrea Martinenghi, Michaela Iva Cellina · 2023 · BioMedInformatics
59. Magnetic resonance elastography of liver and spleen: Methods and applications
    Philippe Garteiser, Sabrina Doblas, Bernard E. VAN BEERS · 2018 · NMR in Biomedicine
60. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease
    Congxiang Shao, Junzhao Ye, Fuxi Li, Shi‐Ting Feng, Wei Wang, Bihui Zhong · 2019 · Digestive and Liver Disease
61. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study
    Abdel Aziz Shaheen, Kiarash Riazi, Alexandra Medellin, Deepak Bhayana, Gilaad G. Kaplan, Jason Jiang, Roy Park, Wendy Schaufert, Kelly W. Burak, Monica Sargious et al. · 2020 · CMAJ Open
62. Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West
    Yi‐Hao Yen, Yu‐Fan Cheng, Jing‐Houng Wang, Chih‐Che Lin, Chih‐Chi Wang · 2021 · PLoS ONE
63. Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients
    Takanori Ito, Vy H. Nguyen, Taku Tanaka, Huiyul Park, Ming‐Lun Yeh, Miwa Kawanaka, Taeang Arai, Masanori Atsukawa, Eileen Laureal Yoon, Pei‐Chien Tsai et al. · 2022 · Clinical Gastroenterology and Hepatology
64. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
    Daniel Clayton‐Chubb, William W. Kemp, Ammar Majeed, John Samuel Lubel, Alex Hodge, Stuart Keith Roberts · 2023 · Nutrients
65. Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta‐analysis
    Zhiwei Yan, Yang Liu, Wei Li, Xiaopeng Zhao, Weichun Lin, Jing Zhang, Shuchun Yu, Jianyong Ma, Jingfeng Wang, Peng Yu et al. · 2022 · European Journal of Clinical Investigation
66. Serum biomarkers for liver fibrosis
    Zhiyang Chen, Yichen Ma, Jingyao Cai, Mei Sun, Ling Zeng, Fengxi Wu, Yiru Zhang, Min Hu · 2022 · Clinica Chimica Acta
67. Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores
    Mazen Noureddin, Edward Mena, Raj Vuppalanchi, Niharika R. Samala, Micaela Wong, Fabiana Pacheco, Prido Polanco, Celine Sakkal, Ani Antaramian, Devon Y. Chang et al. · 2023 · Hepatology Communications
68. Liver Fibrosis Conventional and Molecular Imaging Diagnosis Update
    Shujing Li, Xicui Sun, Minjie Chen, Zhekang Ying, Yamin Wan, Liya Pi, Bin Ren, Qi Cao · 2019 · Journal of Liver
69. Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke
    Neal S. Parikh, Lisa B. VanWagner, Mitchell S.V. Elkind, José Gutierrez · 2019 · Journal of the Neurological Sciences
70. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease
    Yipu Zhao, Hailu Li · 2022 · Scandinavian Journal of Gastroenterology
71. Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review
    Luca Rinaldi, Chiara Giorgione, Andrea Mormone, Francesca Esposito, Michele Rinaldi, Massimiliano Berretta, Raffaele Marfella, Ciro Pasquale Romano · 2023 · Viruses
72. Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
    Kechagias, Stergios, Ekstedt, Mattias, Simonsson, Christian, Nasr, Patrik · 2022 · Hormones
73. Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center
    Yun Hwa Roh, Bo-Kyeong Kang, Dae Won Jun, Chul‐min Lee, Mimi Kim · 2021 · Scientific Reports
74. Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII – an update
    Daniel Segna, Yuly Paulin Mendoza, Naomi Franziska Lange, Susana Gomes Rodrigues, Annalisa Berzigotti · 2022 · Digestive and Liver Disease
75. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease
    Benedikt K. Kaufmann, Nick Seyfried, Daniel Hartmann, Phillipp Hartmann · 2023 · American Journal of Physiology-Gastrointestinal and Liver Physiology
76. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large‐scale multicenter retrospective study
    Hideki Fujii, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Tsubasa Tsutsumi, Takemi Akahane, Chitomi Hasebe, Miwa Kawanaka et al. · 2023 · Hepatology Research
77. Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients
    Congxiang Shao, Junzhao Ye, Fuxi Li, Yansong Lin, Tingfeng Wu, Wei Wang, Shi‐Ting Feng, Bihui Zhong · 2019 · Digestive Diseases and Sciences
78. Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis
    Hidekatsu Kuroda, Yudai Fujiwara, Tamami Abe, Tomoaki Nagasawa, Takuma Oguri, Sachiyo Noguchi, Naohisa Kamiyama, Yasuhiro Takikawa · 2021 · PLoS ONE
79. Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States
    Zhi-Qin Xie, Hongxia Li, Wenliang Tan, Lei Yang, Xiaowu Ma, Wenxin Li, Qingbin Wang, Changzhen Shang, Yajin Chen · 2022 · Frontiers in Nutrition
80. The Role of Noninvasive Tests for Differentiating NASH From NAFL and Diagnosing Advanced Fibrosis Among Patients With NAFLD
    Maya Balakrishnan, Rohit Seth Loomba · 2019 · Journal of Clinical Gastroenterology
81. Profiles of advanced hepatic fibrosis evaluated by FIB‐4 index and shear wave elastography in health checkup examinees
    Sakura Yamamura, Takumi Kawaguchi, Dan Nakano, Yoshiko Tomiyasu, Shinobu Yoshinaga, Yumi Doi, Hirokazu Takahashi, Keizo Anzai, Yuichiro Eguchi, Takuji Torimura et al. · 2019 · Hepatology Research
82. Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients
    Jie Li, An K. Le, Kevin T. Chaung, Linda L Henry, Joseph K. Hoang, Ramsey C Cheung, Mindie H. Nguyen · 2020 · Liver International
83. Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis
    Shengliang Xin, Qiao Zhan, Xiaofan Chen, Jinghang Xu, Yanyan Yu · 2020 · BMC Gastroenterology
84. Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease
    Min Chul Kim, Jeong In Lee, Jung Hee Kim, Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim, Won Sohn · 2020 · PLoS ONE
85. Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting
    Stephen E. Congly, Abdel Aziz Shaheen, Mark G. Swain · 2021 · PLoS ONE
86. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
    Giulio Marchesini, Elisabetta Bugianesi, Patrizia Burra, Fabio Marra, Luca Miele, Anna Alisi, Piero Vajro, Mario Masarone, Salvatore Petta, Marcello Persico et al. · 2021 · Nutrition Metabolism and Cardiovascular Diseases
87. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
    Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Bălteanu, Ramona Cioboată, Alice Elena Ghenea, Suzana Dănoiu, Ana Maria Bumbea, Viorel Biciuşcă · 2023 · Diagnostics
88. Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
    Young Eun Chon, Young‐Joo Jin, Jihyun An, Hee Yeon Kim, Miyoung Choi, Dae Won Jun, Mi Na Kim, Ji Won Han, Han Ah Lee, Jung Hwan Yu et al. · 2024 · Clinical and Molecular Hepatology
89. Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients
    Amanda C. Cheung, Carlos Jose Figueredo, Mary Eugenia Rinella · 2019 · The American Journal of Gastroenterology
90. Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease
    Toshihide Shima, Kyoko Sakai, Hirohisa Oya, Takayuki Katayama, Yasuhide Mitsumoto, Masayuki Mizuno, Yoshihiro Kanbara, Takeshi Okanoue · 2019 · Journal of Gastroenterology
91. Diagnostic value of serological biomarkers for detection of non‐alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV
    Carolyn Yanavich, Antônio Guilherme Pacheco, SW Cardoso, EP Nunes, Ursula Silva Baptista Chaves, Gabriel Reis Pereira de Freitas, Ricardo Ribeiro dos Santos, María María Sánchez Morata, Valdilea Gonçalves Veloso, Beatriz Gilda Jegerhorn Grinsztejn et al. · 2021 · HIV Medicine
92. Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease
    Suzanne R. Sharpton, Nobuharu Tamaki, Ricki Bettencourt, Egbert V. Madamba, Jinho Jung, Amy Y Liu, Cynthia A. Behling, Mark A. Valasek, Rohit Seth Loomba · 2021 · Therapeutic Advances in Gastroenterology
93. Metabolic disease and the liver: A review
    Márcia Vargas, Sheila de Castro Cardoso Toniasso, Patrícia Gabriela Riedel, Camila Pereira Baldin, Francielle Lopes dos Reis, Robson Martins Pereira, Maria Carlota Borba Brum, Dvora Joveleviths, Mário Reis Álvares‐da‐Silva · 2024 · World Journal of Hepatology
94. Association between liver fibrosis and incident dementia in the UK Biobank study
    Neal S. Parikh, Hooman Kamel, Cenai Zhang, Sonal Rajesh Kumar, Russell Evan Rosenblatt, Pascal Spincemaille, Ajay Kumar Gupta, David E. Cohen, Mony J. de Leon, Rebecca F. Gottesman et al. · 2022 · European Journal of Neurology
95. Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
    Clémence M. Canivet, Jérôme Boursier · 2022 · Diagnostics
96. Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)
    Rodrigo O. Moreira, Cynthia Melissa Valério, Cristiane Alves Villela‐Nogueira, Cíntia Cercato, Fernando Gerchman, Ana Maria Lottenberg, Amélio F. Godoy‐Matos, Ricardo de Andrade Oliveira, Carlos Eduardo Brandão‐Mello, Mário Reis Álvares‐da‐Silva et al. · 2023 · Archives of Endocrinology and Metabolism
97. Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery
    Violeta Raverdy, Federica Tavaglione, Estelle Chatelain, Robert J. Caiazzo, Chiara Saponaro, Guillaume Lassailly, Hélène Verkindt, Grégory Baud, Camille Marciniak, Mikaël Chetboun et al. · 2024 · Metabolism
98. The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease
    Yaşar Turan · 2019 · Angiology
99. Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non‐alcoholic fatty liver disease
    Yasushi Honda, Kento Imajo, Takashi Kobayashi, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Masato Yoneda, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima · 2019 · Hepatology Research
100. The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective
     Amr Dokmak, Blanca Lizaola‐Mayo, Hirsh D. Trivedi · 2020 · The American Journal of Medicine